Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jessica Peng"'
Autor:
J. Nicholas O'Donnell, Nathaniel J. Rhodes, Tina Lertharakul, C. Kim Pham, Jessica Peng, Marc H. Scheetz, Cybele Ghossein
Vancomycin is one of the most commonly utilized antibiotics in US hospitals. It remains the drug of choice for the treatment of methicillin-resistant Staphylococcus aureus infections in serious infections. For many of these deep-seated infections, gu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f796f24d51412bf8b0432aaf49515b54
https://europepmc.org/articles/PMC5386811/
https://europepmc.org/articles/PMC5386811/
Autor:
Stephen A. O'Barr, Jessica Peng, Sheryl L. Chow, J. Herbert Patterson, Firooz Pak, Eric Chew, Paryus Patel, Ryan M. Quist, J. Thomas Heywood
Publikováno v:
Circulation: Heart Failure. 4:450-455
Background— Modulation of novel cardiorenal and inflammatory markers may provide insight into the disease process and outcomes of patients with acute decompensated heart failure. Methods and Results— In this open-labeled, prospective, randomized
Publikováno v:
Annals of Pharmacotherapy. 41:556-561
Background: Nesiritide, a synthetic B-type natriuretic peptide, is used for the treatment of patients with acutely decompensated heart failure. Although nesiritide has been reported to worsen renal function, as reflected by significant elevations in
Autor:
Paryus Patel, Eric Chew, Ryan M. Quist, J. Thomas Heywood, J. Herbert Patterson, Firooz Pak, Stephen A. O'Barr, Jessica Peng, Sheryl L. Chow
Publikováno v:
Journal of cardiac failure. 17(3)
Background Rises in serum creatinine and efficacy have been reported as dose-related effects of nesiritide and nitroglycerin in acute decompensated heart failure (ADHF). However, no study has evaluated the comparative safety, efficacy, and biomarkers